Ultragenyx Pharmaceutical reported $0 in Loan Capital for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Loan Capital Change
Acadia Pharmaceuticals ACAD:US $ 0M 0M
Acceleron Pharma XLRN:US $ 0M 0M
Agios Pharmaceuticals AGIO:US $ 0.17M 0.08M
Alexion Pharmaceuticals ALXN:US $ 2388.8M 30.8M
Alnylam Pharmaceuticals ALNY:US $ 433.15M 241.56M
Aptinyx Inc APTX:US $ 0 0
Biocryst Pharmaceuticals BCRX:US $ 263.66M 9.32M
Biomarin Pharmaceutical BMRN:US $ 1077.11M 0.98M
Bluebird Bio BLUE:US $ 0M 0M
Epizyme EPZM:US $ 231.2M 691K
Esperion Therapeutics ESPR:US $ 272.1M 404K
Gw Pharmaceuticals GWPH:US $ 14.16M 0.14M
Insmed INSM:US $ 562.86M 186.87M
IONIS PHARMACEUT IONS:US $ 1240.7M 369.78M
Karyopharm Therapeutics KPTI:US $ 301.38M 59.58M
Kyowa Hakko Kirin 4151:JP Y 14308M 1357M
Macrogenics MGNX:US $ 0 0
Mirati Therapeutics MRTX:US $ 0M 0M
Moderna Inc MRNA:US $ 328M 190M
Neurocrine Biosciences NBIX:US $ 326.3M 4.3M
Ptc Therapeutics PTCT:US $ 1115.38M 3.45M
Puma Biotechnology PBYI:US $ 68.71M 7.64M
Regeneron Pharmaceuticals REGN:US $ 1979.2M 0.3M
Sarepta Therapeutics SRPT:US $ 1092.98M 1.88M
Ultragenyx Pharmaceutical RARE:US $ 0M 0M
Vertex Pharmaceuticals VRTX:US $ 524.92M 5.4M
Vital Therapies VTL:US $ 0M 0M
Xoma XOMA:US $ 0 11.65M